Market Research Logo

US Market Overview for Interventional Oncology Devices 2016 - MedView

The interventional oncology (IO) device market encompasses many different types of methodical approaches to the treatment of cancer. As the cancer epidemic continues to flourish in the U.S., so too do a vast variety of treatment options all designed to increase patient survival, comfort and affordability.


EXECUTIVE SUMMARY FOR COMPLETE REPORT SUITE
1.1 MARKET OVERVIEW
1.2 COMPETITIVE LANDSCAPE
1.3 MARKET TRENDS
1.4 KEY MARKET DEVELOPMENTS
1.5 INCIDENCE RATES INCLUDED
1.6 PROCEDURE NUMBERS
1.7 MARKETS INCLUDED
1.8 KEY REPORT UPDATES
1.9 VERSION HISTORY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
U.S. INTERVENTIONAL ONCOLOGY DEVICE MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 Products
3.1.1.1 Radiation Therapy
3.1.1.2 Ablation Therapy
3.1.1.3 Particle Embolization
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.6 MERGERS AND ACQUISITIONS
CANCER INCIDENCE RATES
4.1 INTRODUCTION
4.2 CANCER BY TYPE
4.2.1 Genital Cancer
4.2.2 Digestive Cancer
4.2.3 Respiratory Cancer
4.2.4 Breast Cancer
4.2.5 Urinary Cancer
4.2.6 Skin Cancer
4.2.7 Lymphoma
4.2.8 Endocrine System Cancer
4.2.9 Leukemia
4.2.10 Oral Cavity/Larynx
4.2.11 Myeloma
4.2.12 Brain/Other Nervous System
4.2.13 Soft Tissue (Non-Heart)
4.2.14 Bones and Joints
4.2.15 Eye and Orbit
ABBREVIATIONS
List of Chart
Chart 1 1: Interventional Oncology Device Market by Segment, U.S., 2012 – 2022 (US$M) 2
Chart 1 2: Interventional Oncology Device Market Overview, U.S., 2015 & 2022 2
Chart 3 1: Interventional Oncology Device Market by Segment, U.S., 2012 – 2022 32
Chart 3 2: Interventional Oncology Device Market Breakdown, U.S., 2015 33
Chart 3 3: Interventional Oncology Device Market Breakdown, U.S., 2022 33
Chart 3 4: Growth by Segment, Interventional Oncology Device Market, U.S., 2012 – 2022 35
Chart 3 5: Leading Competitors, Interventional Oncology Device Market, U.S., 2015 44
Chart 4 1: Male Incidence, Genital Cancer, U.S., 2014 52
Chart 4 2: Male Deaths, Genital Cancer, U.S., 2014 52
Chart 4 3: Female Incidence, Genital Cancer, U.S., 2014 53
Chart 4 4: Female Deaths, Genital Cancer, U.S., 2014 53
Chart 4 5: Male Incidence, Digestive Cancer, U.S., 2014 55
Chart 4 6: Male Deaths, Digestive Cancer, U.S., 2014 55
Chart 4 7: Female Incidence, Digestive Cancer, U.S., 2014 56
Chart 4 8: Female Deaths, Digestive Cancer, U.S., 2014 56
Chart 4 9: Male Incidence, Respiratory Cancer, U.S., 2014 58
Chart 4 10: Male Deaths, Respiratory Cancer, U.S., 2014 58
Chart 4 11: Female Incidence, Respiratory Cancer, U.S., 2014 59
Chart 4 12: Female Deaths, Respiratory Cancer, U.S., 2014 59
Chart 4 13: Incidence by Gender, Breast Cancer, U.S., 2014 61
Chart 4 14: Deaths by Gender, Breast Cancer, U.S., 2014 61
Chart 4 15: Male Incidence, Urinary Cancer, U.S., 2014 63
Chart 4 16: Male Deaths, Urinary Cancer, U.S., 2014 63
Chart 4 17: Female Incidence, Urinary Cancer, U.S., 2014 64
Chart 4 18: Female Deaths, Urinary Cancer, U.S., 2014 64
Chart 4 19: Male Incidence, Skin Cancer, U.S., 2014 66
Chart 4 20: Male Deaths, Skin Cancer, U.S., 2014 66
Chart 4 21: Female Incidence, Skin Cancer, U.S., 2014 67
Chart 4 22: Female Deaths, Skin Cancer, U.S., 2014 67
Chart 4 23: Male Incidence, Lymphoma Cancer, U.S., 2014 69
Chart 4 24: Male Deaths, Lymphoma Cancer, U.S., 2014 69
Chart 4 25: Female Incidence, Lymphoma Cancer, U.S., 2014 70
Chart 4 26: Female Deaths, Lymphoma Cancer, U.S., 2014 70
Chart 4 27: Male Incidence, Endocrine Cancer, U.S., 2014 72
Chart 4 28: Male Deaths, Endocrine Cancer, U.S., 2014 72
Chart 4 29: Female Incidence, Endocrine Cancer, U.S., 2014 73
Chart 4 30: Female Deaths, Endocrine Cancer, U.S., 2014 73
Chart 4 31: Male Incidence, Leukemia Cancer, U.S., 2014 75
Chart 4 32: Male Deaths, Leukemia Cancer, U.S., 2014 75
Chart 4 33: Female Incidence, Leukemia Cancer, U.S., 2014 76
Chart 4 34: Female Deaths, Leukemia Cancer, U.S., 2014 76
Chart 4 35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2014 78
Chart 4 36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2014 78
Chart 4 37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2014 79
Chart 4 38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2014 79
Chart 4 39: Incidence by Gender, Myeloma Cancer, U.S., 2014 81
Chart 4 40: Deaths by Gender, Myeloma Cancer, U.S., 2014 81
Chart 4 41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2014 83
Chart 4 42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2014 83
Chart 4 43: Incidence by Gender, Soft Tissue Cancer, U.S., 2014 85
Chart 4 44: Deaths by Gender, Soft Tissue Cancer, U.S., 2014 85
Chart 4 45: Incidence by Gender, Bone and Joint Cancers, U.S., 2014 87
Chart 4 46: Deaths by Gender, Bone and Joint Cancers, U.S., 2014 87
Chart 4 47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2014 89
Chart 4 48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2014 89
List of Figures
Figure 1 1: Interventional Oncology Device Market Share Ranking by Segment, U.S., 2015 3
Figure 1 2: Companies Research in this Report Suite, U.S., 2015 4
Figure 1 3: Factors Impacting the Interventional Oncology Device Market by Segment, U.S. 5
Figure 1 4: Recent Events in the Interventional Oncology Device Market, U.S., 2012 – 2015 (1 of 3) 6
Figure 1 5: Recent Events in the Interventional Oncology Device Market, U.S., 2012 – 2015 (2 of 3) 7
Figure 1 6: Recent Events in the Interventional Oncology Device Market, U.S., 2012 – 2015 (3 of 3) 8
Figure 1 7: Cancer Incidence Rates Covered, U.S., 2015 (1 of 2) 9
Figure 1 8: Cancer Incidence Rates Covered, U.S., 2015 (2 of 2) 10
Figure 1 9: Interventional Oncology Procedures Covered, U.S., 2015 11
Figure 1 10: Procedural Codes, U.S., 2015 12
Figure 1 11: Interventional Oncology Device Markets Covered, U.S., 2012 – 2022 (1 of 2) 13
Figure 1 12: Interventional Oncology Device Markets Covered, U.S., 2012 – 2022 (2 of 2) 14
Figure 1 13: Key Report Updates, U.S., 2016 15
Figure 1 14: Version History 15
Figure 3 1: Interventional Oncology Device Market by Segment, U.S., 2012 – 2022 (US$M) 31
Figure 3 2: Growth by Segment, Interventional Oncology Device Market, U.S., 2012 – 2022 34
Figure 3 3: Drivers and Limiters, Interventional Oncology Device Market, U.S., 2015 38
Figure 3 4: Leading Competitors, Interventional Oncology Device Market, U.S., 2015 43
Figure 4 1: Genital Cancer Statistics by Type and Gender, U.S., 2014 51
Figure 4 2: Digestive Cancer Statistics by Type and Gender, U.S., 2014 54
Figure 4 3: Respiratory Cancer Statistics by Type and Gender, U.S., 2014 57
Figure 4 4: Breast Cancer Statistics by Type and Gender, U.S., 2014 60
Figure 4 5: Urinary Cancer Statistics by Type and Gender, U.S., 2014 62
Figure 4 6: Skin Cancer Statistics by Type and Gender, U.S., 2014 65
Figure 4 7: Lymphoma Cancer Statistics by Type and Gender, U.S., 2014 68
Figure 4 8: Endocrine Cancer Statistics by Type and Gender, U.S., 2014 71
Figure 4 9: Leukemia Cancer Statistics by Type and Gender, U.S., 2014 74
Figure 4 10: Oral Cavity/Larynx Cancer Statistics by Type and Gender, U.S., 2014 77
Figure 4 11: Myeloma Cancer Statistics by Type and Gender, U.S., 2014 80
Figure 4 12: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2014 82
Figure 4 13: Soft Tissue (Non-Heart) Cancer Statistics by Type and Gender, U.S., 2014 84
Figure 4 14: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014 86
Figure 4 15: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014 88

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report